Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The US Health Department now requires placebo-controlled trials for all new vaccines, sparking debates over updated Covid-19 ...

Moderna, known for its COVID-19 vaccines, has been found guilty of 10 breaches of regulatory code after it marketed its ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

A US pharmaceutical giant could face suspension in the UK for engaging in “unacceptable practices” Read Full Article at ...

Stephanie Armour was formerly a senior special writer for health policy at The Wall Street Journal, where she covered such topics as the Covid-19 pandemic, the Affordable Care Act, Medicaid and ...